대한간호학회지 (Journal of Korean Academy of Nursing)

한국간호과학회 (Korean Society of Nursing Science)
권호 표지
DOI QR코드

DOI QR Code

항호르몬요법을 받는 유방암 환자의 삶의 질 영향 요인

Factors Influencing Quality of Life in Patients with Breast Cancer on Hormone Therapy

  • 황은경 (서울대학교병원) ;
  • 이명선 (서울대학교 간호대학.간호과학연구소)
  • Hwang, Eunkyung (Seoul National University Hospital) ;
  • Yi, Myungsun (College of Nursing, Research Institute of Nursing Science, Seoul National University)
  • 투고 : 2013.08.30
  • 심사 : 2014.02.02
  • 발행 : 2014.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The purpose of the study was to identify degrees of pain, menopause symptoms, and quality of life, and to identify factors influencing quality of life of patients with breast cancer who were on hormone therapy. Methods: A cross-sectional survey design was utilized. Data were collected using questionnaires from 110 patients with breast cancer who had been on hormone therapy for 3 months or more and were being treated at a university hospital in Seoul. Data were analyzed using ${\chi}^2$-test, t-test, ANOVA, Pearson correlation coefficient and multiple linear regression. Results: Mean age of the participants was 53.56 (SD=6.67) and 54 (51.4%) had stage 0 or I at the time of diagnosis. Most of the participants reported having pain and menopause symptoms (88.2% and 95.5% respectively). The mean score for quality of life was $87.84{\pm}21.17$. Pain, menopause symptoms and quality of life had strong correlations with each other (p<.005). Quality of life was explained by menopause symptoms (${\beta}$= -.71), economic status (${\beta}$=.20) and occupation (${\beta}$=.16). Conclusion: The results of the study suggest that menopause symptoms should be incorporated into oncologic nursing care to improve quality of life of patients with breast cancer on hormone therapy.

키워드

참고문헌

  1. Seo HJ. A comparison of the cancer incidence rates between KCCR's registered cancer statistics and NHIC's data of insurance claims [master's thesis]. Seoul: Korea University; 2012.
  2. Korean Breast Cancer Society. The breast. 2nd ed. Seoul: Ilchokak Publishing Co.; 2005.
  3. Fenlon DR, Corner JL, Haviland J. Menopausal hot flushes after breast cancer. European Journal of Cancer Care. 2009;18(2):140-148. http://dx.doi.org/10.1111/j.1365-2354.2007.00902.x
  4. Dorjgochoo T, Gu K, Kallianpur A, Zheng Y, Zheng W, Chen Z, et al. Menopausal symptoms among breast cancer patients 6 months after diagnosis: A report from the Shanghai breast cancer survival study. Menopause (New York, NY). 2009;16(6):1205-1212. http://dx.doi.org/10.1097/gme.0b013e3181aac32b
  5. Patterson RE, Saquib N, Natarajan L, Rock CL, Parker BA, Thomson CA, et al. Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer. Breast Cancer Research and Treatment. 2011;127(2):541-547. http://dx.doi.org/10.1007/s10549-010-1236-x
  6. Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, et al. Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs). Breast Cancer Research and Treatment. 2011;128(2):553-561. http://dx.doi.org/10.1007/s10549-011-1378-5
  7. Fontaine C, Meulemans A, Huizing M, Collen C, Kaufman L, De Mey J, et al. Tolerance of adjuvant letrozole outside of clinical trials. Breast (Edinburgh, Scotland). 2008;17(4):376-381. http://dx.doi.org/10.1016/j.breast.2008.02.006
  8. Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, et al. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet. 2011;378(9793):771-784. http://dx.doi.org/10.1016/s0140-6736(11)60993-8
  9. Hwang SY. Factors affecting quality of life among breast cancer survivors. Mental Health & Social Work. 2009;33:257-287.
  10. Mao JJ, Stricker C, Bruner D, Xie S, Bowman MA, Farrar JT, et al. Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer. 2009;115(16):3631-3639. http://dx.doi.org/10.1002/cncr.24419
  11. Yun YH, Mendoza TR, Heo DS, Yoo T, Heo BY, Park HA, et al. Development of a cancer pain assessment tool in Korea: A validation study of a Korean version of the brief pain inventory. Oncology. 2004;66(6):439-444. http://dx.doi.org/10.1159/000079497
  12. Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods. 2009;41(4):1149-1160. http://dx.doi.org/10.3758/brm.41.4.1149
  13. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11(3): 570-579. https://doi.org/10.1200/JCO.1993.11.3.570
  14. Yoo HJ, Ahn SH, Eremenco S, Kim H, Kim WK, Kim SB, et al. Korean translation and validation of the functional assessment of cancer therapy- breast (FACT-B) scale version 4. Quality of Life Research. 2005;14 (6):1627-1632. https://doi.org/10.1007/s11136-004-7712-1
  15. Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Annals of the Academy of Medicine Singapore. 1994;23(2): 129-138.
  16. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61(2):277-284. https://doi.org/10.1016/0304-3959(94)00178-H
  17. Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, et al. The menopause rating scale (MRS) scale: A methodological review. Health and Quality of Life Outcomes. 2004;2:45. http://dx.doi.org/10.1186/1477-7525-2-45
  18. Reimer T, Gerber B. Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly. Drugs and Aging. 2010;27(10): 791-800. http://dx.doi.org/10.2165/11584700-000000000-00000
  19. Safarinejad MR, Shafiei N, Safarinejad S. Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy. Psycho-Oncology. 2013;22(6):1242-1248. http://dx.doi.org/10.1002/pon.3130
  20. Lee JH. The association of obesity indices and cardiovascular risk in Korean type 2 diabetes. The Korean Journal of Obesity. 2013;22(4):212-214. http://dx.doi.org/10.7570/kjo.2013.22.4.212
  21. Park JH, Jun EY, Kang MY, Joung YS, Kim GS. Symptom experience and quality of life in breast cancer survivors. Journal of Korean Academy of Nursing. 2009;39(5):613-621. http://dx.doi.org/10.4040/jkan.2009.39.5.613
  22. Otte JL, Carpenter JS, Zhong X, Johnstone PA. Feasibility study of acupuncture for reducing sleep disturbances and hot flashes in postmenopausal breast cancer survivors. Clinical Nurse Specialist CNS. 2011; 25(5):228-236. http://dx.doi.org/10.1097/NUR.0b013e318229950b
  23. Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of awareness program for menopausal symptoms in breast cancer survivors: Results from a randomized trial. Supportive Care in Cancer. 2009;17(10):1301-1309. http://dx.doi.org/10.1007/s00520-009-0587-5
  24. Toulis KA, Tzellos T, Kouvelas D, Goulis DG. Gabapentin for the treatment of hot flashes in women with natural or tamoxifen-induced menopause: A systematic review and meta-analysis. Clinical Therapeutics. 2009;31(2):221-235. http://dx.doi.org/10.1016/j.clinthera.2009.02.006
  25. Park J. Symptom cluster and status of physical function in women with breast cancer receiving chemotheraopy [master's thesis]. Seoul: Seoul National University; 2009.
  26. Park H, Yoon HG. Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy. Supportive Care in Cancer. 2013;21(9):2499-2507. http://dx.doi.org/10.1007/s00520-013-1815-6
  27. Kwon EJ, Yi M. Distress and quality of life in breast cancer survivors in Korea. Asian Oncology Nursing. 2012;12(4):289-296. http://dx.doi.org/10.5388/aon.2012.12.4.289

피인용 문헌

  1. 오령지(五靈脂)가 유방암세포의 사멸에 미치는 영향 vol.28, pp.1, 2014, https://doi.org/10.15204/jkobgy.2015.28.1.046
  2. 방사선치료를 받는 유방암 환자의 피로, 수면장애, 삶의 질에 대한 연구 vol.27, pp.2, 2014, https://doi.org/10.7475/kjan.2015.27.2.188
  3. 내면의 힘 측정도구의 타당도 및 신뢰도 검증 vol.16, pp.1, 2014, https://doi.org/10.5388/aon.2016.16.1.38
  4. 유방암 수술 후 유방 암 여성 환자의 의생활 조사: 유방 보존술과 유방 전절제술을 받은 대상자간의 비교 vol.19, pp.1, 2014, https://doi.org/10.14695/kjsos.2016.19.1.49
  5. 유방암 환자의 치료과정에 따른 지지적 관리 요구도의 변화와 삶의 질 vol.16, pp.4, 2014, https://doi.org/10.5388/aon.2016.16.4.217
  6. 유방암 환자 호르몬 복부주사 시 복부피부 마사지와 온열요법이 통증과 불안에 미치는 효과 vol.16, pp.4, 2014, https://doi.org/10.5388/aon.2016.16.4.226
  7. 항호르몬요법을 받는 유방암 여성의 갱년기 증상과 연관 변인간의 분석 vol.23, pp.1, 2014, https://doi.org/10.22650/jkcnr.2017.23.1.120
  8. Validity and Reliability of the Korean Version of the Beliefs about Medicines Questionnaire-Specific for Breast Cancer Patients on Hormone Therapy vol.42, pp.2, 2014, https://doi.org/10.21032/jhis.2017.42.2.136
  9. Predictors of the quality of life in Chinese breast cancer survivors vol.167, pp.2, 2014, https://doi.org/10.1007/s10549-017-4512-1
  10. Effects of Menopausal Symptoms and Depression on the Quality of Life of Premenopausal Women With Breast Cancer in Korea vol.30, pp.1, 2019, https://doi.org/10.1177/1043659618771475
  11. 내분비요법 중인 폐경 전 유방암 환자의 디스트레스 영향 요인 vol.25, pp.1, 2019, https://doi.org/10.22650/jkcnr.2019.25.1.15
  12. Unmet Needs and Quality of Life of Cancer Patients and Their Families: Actor-Partner Interdependence Modeling vol.9, pp.7, 2014, https://doi.org/10.3390/healthcare9070874
  13. Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy vol.8, pp.4, 2014, https://doi.org/10.4103/apjon.apjon-2081